{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:12:58Z","timestamp":1789153978887,"version":"build-2803163510"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"33","license":[{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,15]]},"abstract":"<jats:p>\n                    Inflammatory biomarkers (including C-reactive protein [CRP], interleukin-6 [IL-6], procalcitonin [PCT], and serum amyloid A [SAA]) have been postulated to influence tumorigenesis, yet their causal relevance to breast cancer (BC) remains uncertain. We applied a two-sample Mendelian randomization (MR) framework to evaluate putative causal relationships between these circulating inflammatory factors and BC risk. Publicly available genome-wide association study summary statistics were used to identify, curate, and clump single-nucleotide polymorphisms that robustly trace CRP, IL-6, PCT, and SAA concentrations, which then served as instrumental variables. Causal estimates were generated with inverse-variance weighting, MR-Egger regression, weighted-median, simple-mode, and weighted-mode models. Heterogeneity was assessed by Cochran Q statistic, horizontal pleiotropy by the MR-Egger intercept, and robustness by leave-one-out as well as funnel-plot inspection. Two-sample MR demonstrated that genetically predicted SAA is positively associated with BC risk (inverse-variance weighting odds ratios\u2005=\u20051.002, 95% confidence interval 1.000\u20131.003,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.023), whereas CRP, IL-6, and PCT exhibited no evidence of causal effects on BC in any MR model. Sensitivity analyses showed no substantial heterogeneity or directional pleiotropy, and causal estimates were stable after sequential SNP exclusion. In summary, the present MR study provides genetic evidence that elevated SAA causally increases the risk of developing BC, whereas CRP, IL-6, and PCT do not appear to exert independent causal influences.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000043732","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T19:01:27Z","timestamp":1755543687000},"page":"e43732","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Dissecting the role of inflammatory biomarkers in breast cancer: Insights from Mendelian randomization"],"prefix":"10.1097","volume":"104","author":[{"given":"Xiyin","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Traditional Chinese Medicine, Community Health Service Center of Guali Town of Xiaoshan, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Hu","sequence":"additional","affiliation":[{"name":"The Integrated Traditional Chinese and Western Medicine School of Clinical Medicine, Zhejiang Chinese Medicine University, Hangzhou, China"},{"name":"Department of General Surgery, Tongde Hospital of Zhejiang Province, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260911","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.4161\/cc.8.20.9699","article-title":"Inflammation: a driving force speeds cancer metastasis.","volume":"8","author":"Wu","year":"2009","journal-title":"Cell Cycle"},{"key":"R2-20260911","doi-asserted-by":"crossref","first-page":"3140372","DOI":"10.1155\/2016\/3140372","article-title":"From inflammation to prostate cancer: the role of inflammasomes.","volume":"2016","author":"Karan","year":"2016","journal-title":"Adv Urol"},{"key":"R3-20260911","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1189\/jlb.5MR1216-508R","article-title":"Neutrophils as active regulators of the immune system in the tumor microenvironment.","volume":"102","author":"Shaul","year":"2017","journal-title":"J Leukoc Biol"},{"key":"R4-20260911","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1186\/s12885-018-4229-5","article-title":"Germline breast cancer susceptibility gene mutations and breast cancer outcomes.","volume":"18","author":"Wang","year":"2018","journal-title":"BMC Cancer"},{"key":"R5-20260911","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.breast.2016.05.006","article-title":"Women at high risk of breast cancer: molecular characteristics, clinical presentation and management.","volume":"28","author":"Kleibl","year":"2016","journal-title":"The Breast"},{"key":"R6-20260911","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/hmg\/ddu328","article-title":"Mendelian randomization: genetic anchors for causal inference in epidemiological studies.","volume":"23","author":"Davey Smith","year":"2014","journal-title":"Hum Mol Genet"},{"key":"R7-20260911","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1177\/1745691610383505","article-title":"Mendelian randomization for strengthening causal inference in observational studies: application to Gene \u00d7 Environment interactions.","volume":"5","author":"Smith","year":"2010","journal-title":"Perspect Psychol Sci"},{"key":"R8-20260911","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","article-title":"Interpreting findings from Mendelian randomization using the MR-Egger method.","volume":"32","author":"Burgess","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"R9-20260911","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/add.14038","article-title":"Assessing causal relationships using genetic proxies for exposures: an introduction to Mendelian randomization.","volume":"113","author":"Katikireddi","year":"2017","journal-title":"Addiction"},{"key":"R10-20260911","doi-asserted-by":"crossref","first-page":"R35","DOI":"10.1186\/bcr2891","article-title":"Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer: a cohort study.","volume":"13","author":"Allin","year":"2011","journal-title":"Breast Cancer Res"},{"key":"R11-20260911","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.currproblcancer.2018.05.003","article-title":"Association of elevated levels of C-reactive protein with breast cancer, breast cancer subtypes, and poor outcome.","volume":"43","author":"Kaur","year":"2019","journal-title":"Curr Probl Cancer"},{"key":"R12-20260911","doi-asserted-by":"crossref","first-page":"e40775","DOI":"10.1097\/MD.0000000000040775","article-title":"High C-reactive protein is associated with the efficacy of neoadjuvant chemotherapy for hormone receptor-positive breast cancer.","volume":"103","author":"Hu","year":"2024","journal-title":"Medicine (Baltim)"},{"key":"R13-20260911","doi-asserted-by":"crossref","first-page":"13117","DOI":"10.1038\/s41598-024-65821-8","article-title":"Impending role of inflammatory markers and their specificity and sensitivity in breast cancer patients.","volume":"14","author":"Malik","year":"2024","journal-title":"Sci Rep"},{"key":"R14-20260911","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/milmed\/usz254","article-title":"Proteomic analysis of inflammatory biomarkers associated with breast cancer recurrence.","volume":"185","author":"Bera","year":"2020","journal-title":"Mil Med"},{"key":"R15-20260911","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12935-022-02527-9","article-title":"Tumor-associated macrophage derived IL-6 enriches cancer stem cell population and promotes breast tumor progression via Stat-3 pathway.","volume":"22","author":"Radharani","year":"2022","journal-title":"Cancer Cell Int"},{"key":"R16-20260911","doi-asserted-by":"crossref","first-page":"142879","DOI":"10.1016\/j.ijbiomac.2025.142879","article-title":"Single-cell sequencing exposes mast cell-derived CD52\u2019s anti-tumor action in breast cancer through the IL-6\/JAK\/STAT3 axis.","volume":"310","author":"Jia","year":"2025","journal-title":"Int J Biol Macromol"},{"key":"R17-20260911","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.jare.2016.06.007","article-title":"Hormonal-receptor positive breast cancer: IL-6 augments invasion and lymph node metastasis via stimulating cathepsin B expression.","volume":"7","author":"Ibrahim","year":"2016","journal-title":"J Adv Res"},{"key":"R18-20260911","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/bcpt.13042","article-title":"IL-6 triggers the migration and invasion of oestrogen receptor-negative breast cancer cells via regulation of hippo pathways.","volume":"123","author":"Hou","year":"2018","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"R19-20260911","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12964-018-0309-z","article-title":"Adipocyte-derived IL-6 and leptin promote breast Cancer metastasis via upregulation of Lysyl Hydroxylase-2 expression.","volume":"16","author":"He","year":"2018","journal-title":"Cell Commun Signal"},{"key":"R20-20260911","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.canlet.2021.08.004","article-title":"The novel long noncoding RNA AU021063, induced by IL-6\/Arid5a signaling, exacerbates breast cancer invasion and metastasis by stabilizing Trib3 and activating the Mek\/Erk pathway.","volume":"520","author":"Nyati","year":"2021","journal-title":"Cancer Lett"},{"key":"R21-20260911","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.clinbiochem.2015.07.020","article-title":"Paired measurement of serum amyloid A (SAA) and paraoxonase 1 (PON1) as useful markers in breast cancer recurrence.","volume":"48","author":"Bobin-Dubigeon","year":"2015","journal-title":"Clin Biochem"},{"key":"R22-20260911","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.biopha.2015.10.029","article-title":"Diagnostic importance of S100A9 and S100A12 in breast cancer.","volume":"76","author":"Gunaldi","year":"2015","journal-title":"Biomed Pharmacother"},{"key":"R23-20260911","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/ijc.26462","article-title":"Analysis of acute-phase proteins, AHSG, C3, CLI, HP and SAA, reveals distinctive expression patterns associated with breast, colorectal and lung cancer.","volume":"131","author":"Dowling","year":"2011","journal-title":"Int J Cancer"},{"key":"R24-20260911","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1021\/pr101154j","article-title":"Identification and validation of SAA as a potential lung cancer biomarker and its involvement in metastatic pathogenesis of lung cancer.","volume":"10","author":"Sung","year":"2010","journal-title":"J Proteome Res"},{"key":"R25-20260911","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.3390\/cancers15072176","article-title":"Disequilibrium between BRCA1 and BRCA2 circular and messenger RNAs plays a role in breast cancer.","volume":"15","author":"Levacher","year":"2023","journal-title":"Cancers"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000043732","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:02:01Z","timestamp":1789153321000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000043732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,15]]},"references-count":25,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000043732","relation":{},"ISSN":["1536-5964","0025-7974"],"issn-type":[{"value":"1536-5964","type":"electronic"},{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,15]]},"assertion":[{"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}